Jack A. Khattar, President, CEO at SUPERNUS PHARMACEUTICALS, INC. (SUPN), sold 9,872 shares at $40.40 ($399K) on 2023-01-18, disclosed to the SEC on 2023-01-20.
Open-market sale of $399k SUPN by President, CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $40.40 | 4,936 | $199K | 50.0% |
| 2 | $40.40 | 4,936 | $199K | 50.0% |
| Total | $40.40 avg | 9,872 | $399K | 100% |
| Filing → |
| SUPN | SELL | 2025-10-03 | $183K | — | Filing → |
| SUPN | SELL | 2025-10-02 | $3.9M | — | Filing → |
| SUPN | SELL | 2025-10-01 | $414K | — | Filing → |